nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—Tacrolimus—atopic dermatitis	0.117	0.171	CbGbCtD
Gefitinib—ALB—Tacrolimus—atopic dermatitis	0.0492	0.0721	CbGbCtD
Gefitinib—CYP3A5—Tacrolimus—atopic dermatitis	0.0395	0.0579	CbGbCtD
Gefitinib—ABCG2—Hydrocortisone—atopic dermatitis	0.029	0.0426	CbGbCtD
Gefitinib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0259	0.038	CbGbCtD
Gefitinib—ABCB1—Tacrolimus—atopic dermatitis	0.0257	0.0377	CbGbCtD
Gefitinib—CYP2C19—Loratadine—atopic dermatitis	0.0233	0.0342	CbGbCtD
Gefitinib—CYP2C19—Diphenhydramine—atopic dermatitis	0.0233	0.0342	CbGbCtD
Gefitinib—ALB—Prednisone—atopic dermatitis	0.0199	0.0292	CbGbCtD
Gefitinib—CYP2C9—Loratadine—atopic dermatitis	0.0194	0.0284	CbGbCtD
Gefitinib—CYP2C9—Diphenhydramine—atopic dermatitis	0.0194	0.0284	CbGbCtD
Gefitinib—ABCB1—Loratadine—atopic dermatitis	0.0188	0.0276	CbGbCtD
Gefitinib—ABCG2—Dexamethasone—atopic dermatitis	0.0181	0.0265	CbGbCtD
Gefitinib—CYP2D6—Diphenhydramine—atopic dermatitis	0.0177	0.026	CbGbCtD
Gefitinib—CYP2D6—Loratadine—atopic dermatitis	0.0177	0.026	CbGbCtD
Gefitinib—ABCB1—Methylprednisolone—atopic dermatitis	0.0172	0.0252	CbGbCtD
Gefitinib—CYP1A1—Dexamethasone—atopic dermatitis	0.0167	0.0244	CbGbCtD
Gefitinib—CYP3A5—Hydrocortisone—atopic dermatitis	0.0161	0.0236	CbGbCtD
Gefitinib—CYP3A4—Tacrolimus—atopic dermatitis	0.0154	0.0226	CbGbCtD
Gefitinib—CYP2C19—Prednisone—atopic dermatitis	0.0129	0.0189	CbGbCtD
Gefitinib—CYP3A4—Loratadine—atopic dermatitis	0.0113	0.0165	CbGbCtD
Gefitinib—ABCB1—Betamethasone—atopic dermatitis	0.0112	0.0164	CbGbCtD
Gefitinib—ABCB1—Prednisolone—atopic dermatitis	0.011	0.0162	CbGbCtD
Gefitinib—ABCB1—Hydrocortisone—atopic dermatitis	0.0105	0.0153	CbGbCtD
Gefitinib—ABCB1—Prednisone—atopic dermatitis	0.0104	0.0153	CbGbCtD
Gefitinib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0103	0.0151	CbGbCtD
Gefitinib—CYP3A5—Dexamethasone—atopic dermatitis	0.01	0.0147	CbGbCtD
Gefitinib—CYP2C19—Dexamethasone—atopic dermatitis	0.00807	0.0118	CbGbCtD
Gefitinib—CYP3A4—Triamcinolone—atopic dermatitis	0.00782	0.0115	CbGbCtD
Gefitinib—CYP2C9—Dexamethasone—atopic dermatitis	0.00671	0.00983	CbGbCtD
Gefitinib—CYP3A4—Betamethasone—atopic dermatitis	0.00671	0.00983	CbGbCtD
Gefitinib—CYP3A4—Prednisolone—atopic dermatitis	0.00662	0.0097	CbGbCtD
Gefitinib—ABCB1—Dexamethasone—atopic dermatitis	0.00651	0.00954	CbGbCtD
Gefitinib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00627	0.00919	CbGbCtD
Gefitinib—CYP3A4—Prednisone—atopic dermatitis	0.00625	0.00916	CbGbCtD
Gefitinib—CYP2D6—Dexamethasone—atopic dermatitis	0.00614	0.00899	CbGbCtD
Gefitinib—CYP3A4—Dexamethasone—atopic dermatitis	0.0039	0.00572	CbGbCtD
Gefitinib—CSNK1E—Dexamethasone—Desonide—atopic dermatitis	0.000427	0.075	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Desonide—atopic dermatitis	0.000427	0.075	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Fluocinonide—atopic dermatitis	0.000342	0.0601	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Fluocinonide—atopic dermatitis	0.000342	0.0601	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000332	0.0584	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000332	0.0584	CbGdCrCtD
Gefitinib—Dry mouth—Tacrolimus—atopic dermatitis	0.000282	0.00146	CcSEcCtD
Gefitinib—Pancreatitis—Triamcinolone—atopic dermatitis	0.00028	0.00145	CcSEcCtD
Gefitinib—Pancreatitis—Methylprednisolone—atopic dermatitis	0.000279	0.00145	CcSEcCtD
Gefitinib—Diarrhoea—Loratadine—atopic dermatitis	0.000277	0.00143	CcSEcCtD
Gefitinib—Dry skin—Dexamethasone—atopic dermatitis	0.000275	0.00142	CcSEcCtD
Gefitinib—Dry skin—Betamethasone—atopic dermatitis	0.000275	0.00142	CcSEcCtD
Gefitinib—Infection—Tacrolimus—atopic dermatitis	0.000274	0.00142	CcSEcCtD
Gefitinib—Abdominal pain—Mometasone—atopic dermatitis	0.000274	0.00142	CcSEcCtD
Gefitinib—Body temperature increased—Mometasone—atopic dermatitis	0.000274	0.00142	CcSEcCtD
Gefitinib—Weight decreased—Hydrocortisone—atopic dermatitis	0.000274	0.00142	CcSEcCtD
Gefitinib—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000273	0.00141	CcSEcCtD
Gefitinib—Hypokalaemia—Betamethasone—atopic dermatitis	0.000273	0.00141	CcSEcCtD
Gefitinib—Shock—Tacrolimus—atopic dermatitis	0.000272	0.00141	CcSEcCtD
Gefitinib—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000271	0.0014	CcSEcCtD
Gefitinib—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000271	0.0014	CcSEcCtD
Gefitinib—Infestation—Hydrocortisone—atopic dermatitis	0.00027	0.0014	CcSEcCtD
Gefitinib—Infestation NOS—Hydrocortisone—atopic dermatitis	0.00027	0.0014	CcSEcCtD
Gefitinib—Conjunctivitis—Prednisolone—atopic dermatitis	0.000269	0.00139	CcSEcCtD
Gefitinib—Skin disorder—Tacrolimus—atopic dermatitis	0.000268	0.00139	CcSEcCtD
Gefitinib—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000268	0.00139	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Mometasone—atopic dermatitis	0.000265	0.0466	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Mometasone—atopic dermatitis	0.000265	0.0466	CbGdCrCtD
Gefitinib—Anorexia—Tacrolimus—atopic dermatitis	0.000263	0.00136	CcSEcCtD
Gefitinib—CSNK1E—Danazol—Hydrocortisone—atopic dermatitis	0.000263	0.0462	CbGdCrCtD
Gefitinib—Hypotension—Tacrolimus—atopic dermatitis	0.000258	0.00134	CcSEcCtD
Gefitinib—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000257	0.00133	CcSEcCtD
Gefitinib—Vomiting—Loratadine—atopic dermatitis	0.000257	0.00133	CcSEcCtD
Gefitinib—Rash—Loratadine—atopic dermatitis	0.000255	0.00132	CcSEcCtD
Gefitinib—Dermatitis—Loratadine—atopic dermatitis	0.000255	0.00132	CcSEcCtD
Gefitinib—Infestation—Methylprednisolone—atopic dermatitis	0.000254	0.00132	CcSEcCtD
Gefitinib—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000254	0.00132	CcSEcCtD
Gefitinib—Haemoglobin—Prednisolone—atopic dermatitis	0.00025	0.00129	CcSEcCtD
Gefitinib—Asthenia—Mometasone—atopic dermatitis	0.000249	0.00129	CcSEcCtD
Gefitinib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000249	0.00129	CcSEcCtD
Gefitinib—Haemorrhage—Prednisolone—atopic dermatitis	0.000248	0.00129	CcSEcCtD
Gefitinib—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000247	0.00128	CcSEcCtD
Gefitinib—Dyspnoea—Tacrolimus—atopic dermatitis	0.000246	0.00128	CcSEcCtD
Gefitinib—Pruritus—Mometasone—atopic dermatitis	0.000246	0.00127	CcSEcCtD
Gefitinib—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000244	0.00126	CcSEcCtD
Gefitinib—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000243	0.00126	CcSEcCtD
Gefitinib—Nausea—Loratadine—atopic dermatitis	0.00024	0.00124	CcSEcCtD
Gefitinib—Decreased appetite—Tacrolimus—atopic dermatitis	0.00024	0.00124	CcSEcCtD
Gefitinib—Epistaxis—Triamcinolone—atopic dermatitis	0.00024	0.00124	CcSEcCtD
Gefitinib—Dry skin—Prednisone—atopic dermatitis	0.000239	0.00124	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000239	0.00124	CcSEcCtD
Gefitinib—Fatigue—Tacrolimus—atopic dermatitis	0.000238	0.00123	CcSEcCtD
Gefitinib—Diarrhoea—Mometasone—atopic dermatitis	0.000238	0.00123	CcSEcCtD
Gefitinib—Hypokalaemia—Prednisone—atopic dermatitis	0.000237	0.00123	CcSEcCtD
Gefitinib—Pain—Tacrolimus—atopic dermatitis	0.000236	0.00122	CcSEcCtD
Gefitinib—Constipation—Tacrolimus—atopic dermatitis	0.000236	0.00122	CcSEcCtD
Gefitinib—Weight decreased—Dexamethasone—atopic dermatitis	0.000234	0.00121	CcSEcCtD
Gefitinib—Weight decreased—Betamethasone—atopic dermatitis	0.000234	0.00121	CcSEcCtD
Gefitinib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000231	0.0012	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.00023	0.00119	CcSEcCtD
Gefitinib—Haemoglobin—Triamcinolone—atopic dermatitis	0.00023	0.00119	CcSEcCtD
Gefitinib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000229	0.00119	CcSEcCtD
Gefitinib—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000229	0.00119	CcSEcCtD
Gefitinib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000229	0.00119	CcSEcCtD
Gefitinib—Haemorrhage—Triamcinolone—atopic dermatitis	0.000228	0.00118	CcSEcCtD
Gefitinib—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000228	0.00118	CcSEcCtD
Gefitinib—Eye disorder—Hydrocortisone—atopic dermatitis	0.000227	0.00117	CcSEcCtD
Gefitinib—CSNK1E—Danazol—Prednisone—atopic dermatitis	0.000226	0.0398	CbGdCrCtD
Gefitinib—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000226	0.00117	CcSEcCtD
Gefitinib—Conjunctivitis—Betamethasone—atopic dermatitis	0.000224	0.00116	CcSEcCtD
Gefitinib—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000224	0.00116	CcSEcCtD
Gefitinib—Arrhythmia—Prednisolone—atopic dermatitis	0.000222	0.00115	CcSEcCtD
Gefitinib—Pancreatitis—Prednisone—atopic dermatitis	0.000221	0.00115	CcSEcCtD
Gefitinib—Vomiting—Mometasone—atopic dermatitis	0.000221	0.00114	CcSEcCtD
Gefitinib—Urticaria—Tacrolimus—atopic dermatitis	0.000219	0.00114	CcSEcCtD
Gefitinib—Rash—Mometasone—atopic dermatitis	0.000219	0.00113	CcSEcCtD
Gefitinib—Dermatitis—Mometasone—atopic dermatitis	0.000219	0.00113	CcSEcCtD
Gefitinib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000218	0.00113	CcSEcCtD
Gefitinib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000218	0.00113	CcSEcCtD
Gefitinib—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000217	0.00112	CcSEcCtD
Gefitinib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000216	0.00112	CcSEcCtD
Gefitinib—Eye disorder—Methylprednisolone—atopic dermatitis	0.000213	0.0011	CcSEcCtD
Gefitinib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000212	0.0011	CcSEcCtD
Gefitinib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000211	0.00109	CcSEcCtD
Gefitinib—Haemoglobin—Betamethasone—atopic dermatitis	0.000208	0.00108	CcSEcCtD
Gefitinib—Haemoglobin—Dexamethasone—atopic dermatitis	0.000208	0.00108	CcSEcCtD
Gefitinib—Haemorrhage—Dexamethasone—atopic dermatitis	0.000207	0.00107	CcSEcCtD
Gefitinib—Haemorrhage—Betamethasone—atopic dermatitis	0.000207	0.00107	CcSEcCtD
Gefitinib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000207	0.00107	CcSEcCtD
Gefitinib—Nausea—Mometasone—atopic dermatitis	0.000206	0.00107	CcSEcCtD
Gefitinib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000205	0.00106	CcSEcCtD
Gefitinib—Arrhythmia—Triamcinolone—atopic dermatitis	0.000204	0.00106	CcSEcCtD
Gefitinib—Weight decreased—Prednisone—atopic dermatitis	0.000204	0.00106	CcSEcCtD
Gefitinib—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000204	0.00105	CcSEcCtD
Gefitinib—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000204	0.00105	CcSEcCtD
Gefitinib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000198	0.00103	CcSEcCtD
Gefitinib—Asthenia—Tacrolimus—atopic dermatitis	0.000198	0.00103	CcSEcCtD
Gefitinib—Angioedema—Prednisolone—atopic dermatitis	0.000198	0.00102	CcSEcCtD
Gefitinib—Pruritus—Tacrolimus—atopic dermatitis	0.000195	0.00101	CcSEcCtD
Gefitinib—Malaise—Prednisolone—atopic dermatitis	0.000195	0.00101	CcSEcCtD
Gefitinib—Eye disorder—Betamethasone—atopic dermatitis	0.000194	0.001	CcSEcCtD
Gefitinib—Eye disorder—Dexamethasone—atopic dermatitis	0.000194	0.001	CcSEcCtD
Gefitinib—Angioedema—Hydrocortisone—atopic dermatitis	0.000193	0.001	CcSEcCtD
Gefitinib—Malaise—Hydrocortisone—atopic dermatitis	0.00019	0.000987	CcSEcCtD
Gefitinib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000189	0.000979	CcSEcCtD
Gefitinib—Angiopathy—Dexamethasone—atopic dermatitis	0.000188	0.000974	CcSEcCtD
Gefitinib—Angiopathy—Betamethasone—atopic dermatitis	0.000188	0.000974	CcSEcCtD
Gefitinib—Arrhythmia—Betamethasone—atopic dermatitis	0.000185	0.000959	CcSEcCtD
Gefitinib—Arrhythmia—Dexamethasone—atopic dermatitis	0.000185	0.000959	CcSEcCtD
Gefitinib—Alopecia—Dexamethasone—atopic dermatitis	0.000183	0.000949	CcSEcCtD
Gefitinib—Alopecia—Betamethasone—atopic dermatitis	0.000183	0.000949	CcSEcCtD
Gefitinib—Angioedema—Triamcinolone—atopic dermatitis	0.000182	0.000941	CcSEcCtD
Gefitinib—Haemoglobin—Prednisone—atopic dermatitis	0.000181	0.00094	CcSEcCtD
Gefitinib—Angioedema—Methylprednisolone—atopic dermatitis	0.000181	0.000939	CcSEcCtD
Gefitinib—Haemorrhage—Prednisone—atopic dermatitis	0.00018	0.000935	CcSEcCtD
Gefitinib—Malaise—Triamcinolone—atopic dermatitis	0.000179	0.000929	CcSEcCtD
Gefitinib—Malaise—Methylprednisolone—atopic dermatitis	0.000179	0.000927	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000179	0.000925	CcSEcCtD
Gefitinib—Vomiting—Tacrolimus—atopic dermatitis	0.000176	0.00091	CcSEcCtD
Gefitinib—Rash—Tacrolimus—atopic dermatitis	0.000174	0.000903	CcSEcCtD
Gefitinib—Dermatitis—Tacrolimus—atopic dermatitis	0.000174	0.000902	CcSEcCtD
Gefitinib—Shock—Prednisolone—atopic dermatitis	0.000174	0.0009	CcSEcCtD
Gefitinib—Cough—Triamcinolone—atopic dermatitis	0.000174	0.000899	CcSEcCtD
Gefitinib—Infection—Hydrocortisone—atopic dermatitis	0.000171	0.000887	CcSEcCtD
Gefitinib—Shock—Hydrocortisone—atopic dermatitis	0.00017	0.000879	CcSEcCtD
Gefitinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000169	0.000876	CcSEcCtD
Gefitinib—Eye disorder—Prednisone—atopic dermatitis	0.000169	0.000874	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000168	0.000869	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000168	0.0295	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Hydrocortisone—atopic dermatitis	0.000168	0.0295	CbGdCrCtD
Gefitinib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000167	0.000867	CcSEcCtD
Gefitinib—Dry mouth—Triamcinolone—atopic dermatitis	0.000166	0.000858	CcSEcCtD
Gefitinib—Angioedema—Dexamethasone—atopic dermatitis	0.000165	0.000854	CcSEcCtD
Gefitinib—Angioedema—Betamethasone—atopic dermatitis	0.000165	0.000854	CcSEcCtD
Gefitinib—Anorexia—Hydrocortisone—atopic dermatitis	0.000164	0.000851	CcSEcCtD
Gefitinib—Nausea—Tacrolimus—atopic dermatitis	0.000164	0.00085	CcSEcCtD
Gefitinib—Angiopathy—Prednisone—atopic dermatitis	0.000164	0.000848	CcSEcCtD
Gefitinib—Malaise—Dexamethasone—atopic dermatitis	0.000163	0.000843	CcSEcCtD
Gefitinib—Malaise—Betamethasone—atopic dermatitis	0.000163	0.000843	CcSEcCtD
Gefitinib—CHEK2—Testosterone Propionate—Hydrocortisone—atopic dermatitis	0.000162	0.0284	CbGdCrCtD
Gefitinib—Arrhythmia—Prednisone—atopic dermatitis	0.000161	0.000835	CcSEcCtD
Gefitinib—Infection—Triamcinolone—atopic dermatitis	0.000161	0.000835	CcSEcCtD
Gefitinib—Hypotension—Hydrocortisone—atopic dermatitis	0.000161	0.000834	CcSEcCtD
Gefitinib—Infection—Methylprednisolone—atopic dermatitis	0.000161	0.000833	CcSEcCtD
Gefitinib—Shock—Triamcinolone—atopic dermatitis	0.00016	0.000827	CcSEcCtD
Gefitinib—Alopecia—Prednisone—atopic dermatitis	0.000159	0.000826	CcSEcCtD
Gefitinib—Shock—Methylprednisolone—atopic dermatitis	0.000159	0.000825	CcSEcCtD
Gefitinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000159	0.000823	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Methylprednisolone—atopic dermatitis	0.000158	0.0278	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000158	0.0278	CbGdCrCtD
Gefitinib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000157	0.000815	CcSEcCtD
Gefitinib—Malnutrition—Prednisone—atopic dermatitis	0.000157	0.000814	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Betamethasone—atopic dermatitis	0.000156	0.0274	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Dexamethasone—atopic dermatitis	0.000156	0.0274	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Triamcinolone—atopic dermatitis	0.000152	0.0268	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Triamcinolone—atopic dermatitis	0.000152	0.0268	CbGdCrCtD
Gefitinib—Hypotension—Methylprednisolone—atopic dermatitis	0.000151	0.000784	CcSEcCtD
Gefitinib—Pain—Prednisolone—atopic dermatitis	0.000151	0.000782	CcSEcCtD
Gefitinib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.00015	0.000776	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000149	0.000771	CcSEcCtD
Gefitinib—Fatigue—Hydrocortisone—atopic dermatitis	0.000149	0.00077	CcSEcCtD
Gefitinib—Pain—Hydrocortisone—atopic dermatitis	0.000147	0.000764	CcSEcCtD
Gefitinib—Infection—Betamethasone—atopic dermatitis	0.000146	0.000758	CcSEcCtD
Gefitinib—Infection—Dexamethasone—atopic dermatitis	0.000146	0.000758	CcSEcCtD
Gefitinib—Anaemia—Prednisone—atopic dermatitis	0.000145	0.000752	CcSEcCtD
Gefitinib—Shock—Betamethasone—atopic dermatitis	0.000145	0.000751	CcSEcCtD
Gefitinib—Shock—Dexamethasone—atopic dermatitis	0.000145	0.000751	CcSEcCtD
Gefitinib—Dyspnoea—Triamcinolone—atopic dermatitis	0.000145	0.00075	CcSEcCtD
Gefitinib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000144	0.000748	CcSEcCtD
Gefitinib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000144	0.000748	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Prednisone—atopic dermatitis	0.000144	0.0254	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisone—atopic dermatitis	0.000144	0.0254	CbGdCrCtD
Gefitinib—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000144	0.000747	CcSEcCtD
Gefitinib—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000144	0.000747	CcSEcCtD
Gefitinib—Angioedema—Prednisone—atopic dermatitis	0.000144	0.000744	CcSEcCtD
Gefitinib—Malaise—Prednisone—atopic dermatitis	0.000142	0.000734	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Prednisolone—atopic dermatitis	0.000141	0.0248	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisolone—atopic dermatitis	0.000141	0.0248	CbGdCrCtD
Gefitinib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000141	0.00073	CcSEcCtD
Gefitinib—Anorexia—Betamethasone—atopic dermatitis	0.00014	0.000727	CcSEcCtD
Gefitinib—Anorexia—Dexamethasone—atopic dermatitis	0.00014	0.000727	CcSEcCtD
Gefitinib—Urticaria—Prednisolone—atopic dermatitis	0.00014	0.000726	CcSEcCtD
Gefitinib—Fatigue—Triamcinolone—atopic dermatitis	0.00014	0.000725	CcSEcCtD
Gefitinib—Fatigue—Methylprednisolone—atopic dermatitis	0.00014	0.000723	CcSEcCtD
Gefitinib—Pain—Triamcinolone—atopic dermatitis	0.000139	0.000719	CcSEcCtD
Gefitinib—Hypotension—Betamethasone—atopic dermatitis	0.000138	0.000713	CcSEcCtD
Gefitinib—Hypotension—Dexamethasone—atopic dermatitis	0.000138	0.000713	CcSEcCtD
Gefitinib—Urticaria—Hydrocortisone—atopic dermatitis	0.000137	0.000709	CcSEcCtD
Gefitinib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000136	0.000706	CcSEcCtD
Gefitinib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000136	0.000706	CcSEcCtD
Gefitinib—CHEK2—Danazol—Hydrocortisone—atopic dermatitis	0.000134	0.0236	CbGdCrCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000133	0.000688	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000132	0.000686	CcSEcCtD
Gefitinib—Hypersensitivity—Prednisolone—atopic dermatitis	0.00013	0.000674	CcSEcCtD
Gefitinib—Urticaria—Triamcinolone—atopic dermatitis	0.000129	0.000668	CcSEcCtD
Gefitinib—Urticaria—Methylprednisolone—atopic dermatitis	0.000129	0.000666	CcSEcCtD
Gefitinib—Body temperature increased—Triamcinolone—atopic dermatitis	0.000128	0.000665	CcSEcCtD
Gefitinib—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000128	0.000663	CcSEcCtD
Gefitinib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000128	0.000663	CcSEcCtD
Gefitinib—Decreased appetite—Betamethasone—atopic dermatitis	0.000128	0.000663	CcSEcCtD
Gefitinib—Infection—Prednisone—atopic dermatitis	0.000127	0.00066	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000127	0.000659	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000127	0.000659	CcSEcCtD
Gefitinib—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000127	0.000658	CcSEcCtD
Gefitinib—Fatigue—Dexamethasone—atopic dermatitis	0.000127	0.000658	CcSEcCtD
Gefitinib—Fatigue—Betamethasone—atopic dermatitis	0.000127	0.000658	CcSEcCtD
Gefitinib—Shock—Prednisone—atopic dermatitis	0.000126	0.000654	CcSEcCtD
Gefitinib—Pain—Betamethasone—atopic dermatitis	0.000126	0.000652	CcSEcCtD
Gefitinib—Pain—Dexamethasone—atopic dermatitis	0.000126	0.000652	CcSEcCtD
Gefitinib—Nervous system disorder—Prednisone—atopic dermatitis	0.000126	0.000652	CcSEcCtD
Gefitinib—Skin disorder—Prednisone—atopic dermatitis	0.000125	0.000645	CcSEcCtD
Gefitinib—Asthenia—Hydrocortisone—atopic dermatitis	0.000124	0.000641	CcSEcCtD
Gefitinib—Anorexia—Prednisone—atopic dermatitis	0.000122	0.000633	CcSEcCtD
Gefitinib—Pruritus—Hydrocortisone—atopic dermatitis	0.000122	0.000632	CcSEcCtD
Gefitinib—CHEK2—Norethindrone—Hydrocortisone—atopic dermatitis	0.000121	0.0213	CbGdCrCtD
Gefitinib—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.00012	0.000624	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.00012	0.000624	CcSEcCtD
Gefitinib—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00012	0.000619	CcSEcCtD
Gefitinib—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000119	0.000618	CcSEcCtD
Gefitinib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000118	0.000611	CcSEcCtD
Gefitinib—Urticaria—Dexamethasone—atopic dermatitis	0.000117	0.000606	CcSEcCtD
Gefitinib—Urticaria—Betamethasone—atopic dermatitis	0.000117	0.000606	CcSEcCtD
Gefitinib—Asthenia—Triamcinolone—atopic dermatitis	0.000116	0.000603	CcSEcCtD
Gefitinib—Abdominal pain—Dexamethasone—atopic dermatitis	0.000116	0.000603	CcSEcCtD
Gefitinib—Body temperature increased—Dexamethasone—atopic dermatitis	0.000116	0.000603	CcSEcCtD
Gefitinib—Body temperature increased—Betamethasone—atopic dermatitis	0.000116	0.000603	CcSEcCtD
Gefitinib—Abdominal pain—Betamethasone—atopic dermatitis	0.000116	0.000603	CcSEcCtD
Gefitinib—Asthenia—Methylprednisolone—atopic dermatitis	0.000116	0.000602	CcSEcCtD
Gefitinib—CHEK2—Danazol—Prednisone—atopic dermatitis	0.000116	0.0204	CbGdCrCtD
Gefitinib—Pruritus—Triamcinolone—atopic dermatitis	0.000115	0.000595	CcSEcCtD
Gefitinib—Pruritus—Methylprednisolone—atopic dermatitis	0.000115	0.000594	CcSEcCtD
Gefitinib—SBK1—head—atopic dermatitis	0.000112	0.11	CbGeAlD
Gefitinib—Decreased appetite—Prednisone—atopic dermatitis	0.000111	0.000578	CcSEcCtD
Gefitinib—Rash—Prednisolone—atopic dermatitis	0.000111	0.000576	CcSEcCtD
Gefitinib—Dermatitis—Prednisolone—atopic dermatitis	0.000111	0.000576	CcSEcCtD
Gefitinib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000111	0.000574	CcSEcCtD
Gefitinib—Fatigue—Prednisone—atopic dermatitis	0.000111	0.000573	CcSEcCtD
Gefitinib—Constipation—Prednisone—atopic dermatitis	0.00011	0.000568	CcSEcCtD
Gefitinib—Vomiting—Hydrocortisone—atopic dermatitis	0.00011	0.000568	CcSEcCtD
Gefitinib—Rash—Hydrocortisone—atopic dermatitis	0.000109	0.000563	CcSEcCtD
Gefitinib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000109	0.000563	CcSEcCtD
Gefitinib—Asthenia—Betamethasone—atopic dermatitis	0.000106	0.000547	CcSEcCtD
Gefitinib—Asthenia—Dexamethasone—atopic dermatitis	0.000106	0.000547	CcSEcCtD
Gefitinib—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000105	0.000543	CcSEcCtD
Gefitinib—Nausea—Prednisolone—atopic dermatitis	0.000105	0.000543	CcSEcCtD
Gefitinib—Pruritus—Dexamethasone—atopic dermatitis	0.000104	0.00054	CcSEcCtD
Gefitinib—Pruritus—Betamethasone—atopic dermatitis	0.000104	0.00054	CcSEcCtD
Gefitinib—Vomiting—Triamcinolone—atopic dermatitis	0.000103	0.000535	CcSEcCtD
Gefitinib—Vomiting—Methylprednisolone—atopic dermatitis	0.000103	0.000533	CcSEcCtD
Gefitinib—Nausea—Hydrocortisone—atopic dermatitis	0.000102	0.00053	CcSEcCtD
Gefitinib—Rash—Triamcinolone—atopic dermatitis	0.000102	0.00053	CcSEcCtD
Gefitinib—Dermatitis—Triamcinolone—atopic dermatitis	0.000102	0.00053	CcSEcCtD
Gefitinib—Rash—Methylprednisolone—atopic dermatitis	0.000102	0.000529	CcSEcCtD
Gefitinib—Dermatitis—Methylprednisolone—atopic dermatitis	0.000102	0.000528	CcSEcCtD
Gefitinib—Urticaria—Prednisone—atopic dermatitis	0.000102	0.000528	CcSEcCtD
Gefitinib—Abdominal pain—Prednisone—atopic dermatitis	0.000101	0.000525	CcSEcCtD
Gefitinib—Body temperature increased—Prednisone—atopic dermatitis	0.000101	0.000525	CcSEcCtD
Gefitinib—Diarrhoea—Dexamethasone—atopic dermatitis	0.000101	0.000522	CcSEcCtD
Gefitinib—Diarrhoea—Betamethasone—atopic dermatitis	0.000101	0.000522	CcSEcCtD
Gefitinib—CHEK2—Levonorgestrel—Hydrocortisone—atopic dermatitis	9.64e-05	0.017	CbGdCrCtD
Gefitinib—Nausea—Triamcinolone—atopic dermatitis	9.64e-05	0.000499	CcSEcCtD
Gefitinib—Nausea—Methylprednisolone—atopic dermatitis	9.62e-05	0.000498	CcSEcCtD
Gefitinib—CSNK1E—skin of body—atopic dermatitis	9.47e-05	0.0935	CbGeAlD
Gefitinib—Hypersensitivity—Prednisone—atopic dermatitis	9.45e-05	0.00049	CcSEcCtD
Gefitinib—CYP1A1—skin epidermis—atopic dermatitis	9.4e-05	0.0929	CbGeAlD
Gefitinib—Vomiting—Dexamethasone—atopic dermatitis	9.36e-05	0.000485	CcSEcCtD
Gefitinib—Vomiting—Betamethasone—atopic dermatitis	9.36e-05	0.000485	CcSEcCtD
Gefitinib—Rash—Betamethasone—atopic dermatitis	9.28e-05	0.000481	CcSEcCtD
Gefitinib—Rash—Dexamethasone—atopic dermatitis	9.28e-05	0.000481	CcSEcCtD
Gefitinib—Dermatitis—Dexamethasone—atopic dermatitis	9.28e-05	0.000481	CcSEcCtD
Gefitinib—Dermatitis—Betamethasone—atopic dermatitis	9.28e-05	0.000481	CcSEcCtD
Gefitinib—Asthenia—Prednisone—atopic dermatitis	9.2e-05	0.000477	CcSEcCtD
Gefitinib—ERBB3—skin of body—atopic dermatitis	9.14e-05	0.0902	CbGeAlD
Gefitinib—Pruritus—Prednisone—atopic dermatitis	9.07e-05	0.00047	CcSEcCtD
Gefitinib—Diarrhoea—Prednisone—atopic dermatitis	8.77e-05	0.000455	CcSEcCtD
Gefitinib—Nausea—Dexamethasone—atopic dermatitis	8.75e-05	0.000453	CcSEcCtD
Gefitinib—Nausea—Betamethasone—atopic dermatitis	8.75e-05	0.000453	CcSEcCtD
Gefitinib—EPHA6—head—atopic dermatitis	8.74e-05	0.0863	CbGeAlD
Gefitinib—Vomiting—Prednisone—atopic dermatitis	8.15e-05	0.000422	CcSEcCtD
Gefitinib—Rash—Prednisone—atopic dermatitis	8.09e-05	0.000419	CcSEcCtD
Gefitinib—Dermatitis—Prednisone—atopic dermatitis	8.08e-05	0.000419	CcSEcCtD
Gefitinib—MAP3K19—head—atopic dermatitis	7.94e-05	0.0784	CbGeAlD
Gefitinib—Nausea—Prednisone—atopic dermatitis	7.62e-05	0.000395	CcSEcCtD
Gefitinib—CSNK1E—head—atopic dermatitis	6.18e-05	0.061	CbGeAlD
Gefitinib—IRAK4—head—atopic dermatitis	6.08e-05	0.0601	CbGeAlD
Gefitinib—ERBB3—head—atopic dermatitis	5.96e-05	0.0589	CbGeAlD
Gefitinib—MKNK2—head—atopic dermatitis	5.67e-05	0.056	CbGeAlD
Gefitinib—MKNK1—head—atopic dermatitis	5.6e-05	0.0553	CbGeAlD
Gefitinib—STK10—head—atopic dermatitis	4.61e-05	0.0455	CbGeAlD
Gefitinib—EGFR—Adaptive Immune System—CD79A—atopic dermatitis	4.27e-05	0.000363	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—MAPK8—atopic dermatitis	4.24e-05	0.00036	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.23e-05	0.000359	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCR3—atopic dermatitis	4.2e-05	0.000357	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SELE—atopic dermatitis	4.19e-05	0.000356	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NFKBIA—atopic dermatitis	4.16e-05	0.000353	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CCR5—atopic dermatitis	4.16e-05	0.000353	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CCL5—atopic dermatitis	4.16e-05	0.000353	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CMA1—atopic dermatitis	4.14e-05	0.000351	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL11—atopic dermatitis	4.14e-05	0.000351	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TLR2—atopic dermatitis	4.12e-05	0.00035	CbGpPWpGaD
Gefitinib—MAP2K5—head—atopic dermatitis	4.12e-05	0.0406	CbGeAlD
Gefitinib—ABCG2—Metabolism—GLB1—atopic dermatitis	4.08e-05	0.000346	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCR3—atopic dermatitis	4.05e-05	0.000344	CbGpPWpGaD
Gefitinib—EGFR—Immune System—STAT6—atopic dermatitis	4.02e-05	0.000341	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—IL6—atopic dermatitis	3.97e-05	0.000337	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—MAPK8—atopic dermatitis	3.93e-05	0.000334	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CARD11—atopic dermatitis	3.91e-05	0.000332	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADSL—atopic dermatitis	3.91e-05	0.000332	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—STAT6—atopic dermatitis	3.89e-05	0.00033	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD79A—atopic dermatitis	3.88e-05	0.000329	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NGF—atopic dermatitis	3.85e-05	0.000327	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL27—atopic dermatitis	3.83e-05	0.000325	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCR3—atopic dermatitis	3.82e-05	0.000324	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL18—atopic dermatitis	3.81e-05	0.000323	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL10—atopic dermatitis	3.76e-05	0.000319	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD8A—atopic dermatitis	3.75e-05	0.000318	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CASP8—atopic dermatitis	3.75e-05	0.000318	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NPS—atopic dermatitis	3.75e-05	0.000318	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TAC1—atopic dermatitis	3.75e-05	0.000318	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CCR5—atopic dermatitis	3.75e-05	0.000318	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TNF—atopic dermatitis	3.71e-05	0.000314	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CD4—atopic dermatitis	3.7e-05	0.000314	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCR3—atopic dermatitis	3.67e-05	0.000312	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NFKBIA—atopic dermatitis	3.65e-05	0.00031	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—IL6—atopic dermatitis	3.64e-05	0.000309	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—IL6—atopic dermatitis	3.64e-05	0.000309	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NPS—atopic dermatitis	3.61e-05	0.000306	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TAC1—atopic dermatitis	3.61e-05	0.000306	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.6e-05	0.000305	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	3.58e-05	0.000304	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—PPARA—atopic dermatitis	3.56e-05	0.000302	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD4—atopic dermatitis	3.55e-05	0.000302	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCR3—atopic dermatitis	3.54e-05	0.0003	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—IL6—atopic dermatitis	3.53e-05	0.000299	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—IL6—atopic dermatitis	3.51e-05	0.000298	CbGpPWpGaD
Gefitinib—EGFR—Disease—SLC11A1—atopic dermatitis	3.49e-05	0.000296	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL5—atopic dermatitis	3.48e-05	0.000295	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD8A—atopic dermatitis	3.45e-05	0.000292	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—IL6—atopic dermatitis	3.44e-05	0.000292	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL17—atopic dermatitis	3.43e-05	0.000291	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.42e-05	0.00029	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—NPS—atopic dermatitis	3.4e-05	0.000289	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TAC1—atopic dermatitis	3.4e-05	0.000289	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.4e-05	0.000289	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCR3—atopic dermatitis	3.37e-05	0.000286	CbGpPWpGaD
Gefitinib—MKNK1—Disease—CD4—atopic dermatitis	3.36e-05	0.000285	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL5—atopic dermatitis	3.36e-05	0.000285	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.34e-05	0.000284	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCR3—atopic dermatitis	3.34e-05	0.000283	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CASP8—atopic dermatitis	3.29e-05	0.000279	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—IL6—atopic dermatitis	3.29e-05	0.000279	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—IL6—atopic dermatitis	3.24e-05	0.000275	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CCL5—atopic dermatitis	3.23e-05	0.000274	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NFKBIA—atopic dermatitis	3.18e-05	0.000269	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL5—atopic dermatitis	3.18e-05	0.000269	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL18—atopic dermatitis	3.17e-05	0.000269	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CCR5—atopic dermatitis	3.17e-05	0.000269	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL5—atopic dermatitis	3.16e-05	0.000268	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.15e-05	0.000267	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—MAPK8—atopic dermatitis	3.13e-05	0.000266	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD8A—atopic dermatitis	3.12e-05	0.000265	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—IL6—atopic dermatitis	3.09e-05	0.000263	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CD4—atopic dermatitis	3.08e-05	0.000261	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—IL6—atopic dermatitis	3.08e-05	0.000261	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.07e-05	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—IL6—atopic dermatitis	3.06e-05	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—MAPK8—atopic dermatitis	3.06e-05	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KIF3A—atopic dermatitis	3.06e-05	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CASP1—atopic dermatitis	3.05e-05	0.000259	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—IL6—atopic dermatitis	3.05e-05	0.000259	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NPS—atopic dermatitis	3.01e-05	0.000255	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TAC1—atopic dermatitis	3.01e-05	0.000255	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NGF—atopic dermatitis	2.99e-05	0.000254	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	2.97e-05	0.000252	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL10—atopic dermatitis	2.97e-05	0.000252	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCR3—atopic dermatitis	2.95e-05	0.00025	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—IL6—atopic dermatitis	2.92e-05	0.000248	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GLB1—atopic dermatitis	2.92e-05	0.000248	CbGpPWpGaD
Gefitinib—CYP1A1—skin of body—atopic dermatitis	2.91e-05	0.0288	CbGeAlD
Gefitinib—CSNK1E—Signaling Pathways—CCR5—atopic dermatitis	2.91e-05	0.000247	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NFKBIA—atopic dermatitis	2.91e-05	0.000247	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL5—atopic dermatitis	2.89e-05	0.000245	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	2.89e-05	0.000245	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—IL6—atopic dermatitis	2.87e-05	0.000243	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.87e-05	0.000243	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—IL6—atopic dermatitis	2.87e-05	0.000243	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL10—atopic dermatitis	2.86e-05	0.000243	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—IL6—atopic dermatitis	2.84e-05	0.000241	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.82e-05	0.00024	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—IL6—atopic dermatitis	2.82e-05	0.000239	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—IL6—atopic dermatitis	2.8e-05	0.000238	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IFNG—atopic dermatitis	2.8e-05	0.000238	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADSL—atopic dermatitis	2.8e-05	0.000238	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL5—atopic dermatitis	2.79e-05	0.000237	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKBIA—atopic dermatitis	2.78e-05	0.000236	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CMA1—atopic dermatitis	2.77e-05	0.000235	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL11—atopic dermatitis	2.77e-05	0.000235	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GLB1—atopic dermatitis	2.76e-05	0.000234	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR2—atopic dermatitis	2.76e-05	0.000234	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD4—atopic dermatitis	2.7e-05	0.000229	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL10—atopic dermatitis	2.7e-05	0.000229	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKBIA—atopic dermatitis	2.67e-05	0.000227	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADSL—atopic dermatitis	2.64e-05	0.000224	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CASP8—atopic dermatitis	2.63e-05	0.000223	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CD4—atopic dermatitis	2.61e-05	0.000222	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—MAPK8—atopic dermatitis	2.61e-05	0.000221	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—STAT6—atopic dermatitis	2.6e-05	0.000221	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD79A—atopic dermatitis	2.59e-05	0.00022	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL5—atopic dermatitis	2.56e-05	0.000217	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.54e-05	0.000216	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GLB1—atopic dermatitis	2.51e-05	0.000213	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—IL6—atopic dermatitis	2.51e-05	0.000213	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CASP8—atopic dermatitis	2.51e-05	0.000213	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL1B—atopic dermatitis	2.5e-05	0.000212	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL2—atopic dermatitis	2.49e-05	0.000211	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKBIA—atopic dermatitis	2.47e-05	0.00021	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL5—atopic dermatitis	2.46e-05	0.000209	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.45e-05	0.000208	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKBIA—atopic dermatitis	2.42e-05	0.000206	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADSL—atopic dermatitis	2.41e-05	0.000205	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL10—atopic dermatitis	2.38e-05	0.000202	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NGF—atopic dermatitis	2.37e-05	0.000201	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	2.35e-05	0.0002	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL5—atopic dermatitis	2.32e-05	0.000197	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCR5—atopic dermatitis	2.3e-05	0.000195	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—MAPK8—atopic dermatitis	2.29e-05	0.000194	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NGF—atopic dermatitis	2.28e-05	0.000194	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-05	0.000192	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GLB1—atopic dermatitis	2.26e-05	0.000192	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR3—atopic dermatitis	2.26e-05	0.000191	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IFNG—atopic dermatitis	2.23e-05	0.000189	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCR5—atopic dermatitis	2.22e-05	0.000188	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GLB1—atopic dermatitis	2.2e-05	0.000187	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CASP8—atopic dermatitis	2.19e-05	0.000185	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADSL—atopic dermatitis	2.16e-05	0.000184	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL2—atopic dermatitis	2.16e-05	0.000184	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD4—atopic dermatitis	2.16e-05	0.000183	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.13e-05	0.000181	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL18—atopic dermatitis	2.12e-05	0.00018	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADSL—atopic dermatitis	2.11e-05	0.000179	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCR5—atopic dermatitis	2.09e-05	0.000177	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD8A—atopic dermatitis	2.09e-05	0.000177	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.08e-05	0.000176	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—atopic dermatitis	2.06e-05	0.000175	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.06e-05	0.000175	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL5—atopic dermatitis	2.05e-05	0.000174	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.01e-05	0.000171	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NPS—atopic dermatitis	2.01e-05	0.000171	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TAC1—atopic dermatitis	2.01e-05	0.000171	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—atopic dermatitis	2e-05	0.00017	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MAPK8—atopic dermatitis	1.99e-05	0.000169	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—atopic dermatitis	1.99e-05	0.000169	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.99e-05	0.000169	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—atopic dermatitis	1.99e-05	0.000169	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL2—atopic dermatitis	1.98e-05	0.000168	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—atopic dermatitis	1.98e-05	0.000168	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.97e-05	0.000167	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCR3—atopic dermatitis	1.97e-05	0.000167	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—atopic dermatitis	1.95e-05	0.000166	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKBIA—atopic dermatitis	1.95e-05	0.000166	CbGpPWpGaD
Gefitinib—CYP1A1—head—atopic dermatitis	1.9e-05	0.0188	CbGeAlD
Gefitinib—IRAK1—Signaling Pathways—NGF—atopic dermatitis	1.9e-05	0.000161	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKBIA—atopic dermatitis	1.88e-05	0.00016	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL5—atopic dermatitis	1.87e-05	0.000159	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—atopic dermatitis	1.86e-05	0.000158	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCR5—atopic dermatitis	1.85e-05	0.000157	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.83e-05	0.000155	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—MAPK8—atopic dermatitis	1.83e-05	0.000155	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—atopic dermatitis	1.82e-05	0.000154	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—atopic dermatitis	1.79e-05	0.000152	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—atopic dermatitis	1.77e-05	0.00015	CbGpPWpGaD
Gefitinib—EGFR—Disease—CCR5—atopic dermatitis	1.76e-05	0.00015	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL8—atopic dermatitis	1.76e-05	0.000149	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—MAPK8—atopic dermatitis	1.75e-05	0.000148	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.74e-05	0.000148	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.69e-05	0.000143	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—atopic dermatitis	1.68e-05	0.000143	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—atopic dermatitis	1.67e-05	0.000141	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—atopic dermatitis	1.66e-05	0.000141	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—atopic dermatitis	1.65e-05	0.00014	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.65e-05	0.00014	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKBIA—atopic dermatitis	1.62e-05	0.000137	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL10—atopic dermatitis	1.59e-05	0.000135	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.57e-05	0.000133	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—atopic dermatitis	1.56e-05	0.000133	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MAPK8—atopic dermatitis	1.55e-05	0.000131	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.53e-05	0.00013	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—MAPK8—atopic dermatitis	1.52e-05	0.000129	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.5e-05	0.000127	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—atopic dermatitis	1.46e-05	0.000124	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CASP8—atopic dermatitis	1.46e-05	0.000124	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—atopic dermatitis	1.41e-05	0.00012	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL8—atopic dermatitis	1.39e-05	0.000118	CbGpPWpGaD
Gefitinib—CYP2D6—head—atopic dermatitis	1.37e-05	0.0136	CbGeAlD
Gefitinib—EGFR—Signaling Pathways—CCL5—atopic dermatitis	1.37e-05	0.000116	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.36e-05	0.000115	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL8—atopic dermatitis	1.34e-05	0.000114	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—atopic dermatitis	1.33e-05	0.000113	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARA—atopic dermatitis	1.32e-05	0.000112	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.3e-05	0.00011	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—atopic dermatitis	1.28e-05	0.000109	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—atopic dermatitis	1.27e-05	0.000108	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NGF—atopic dermatitis	1.27e-05	0.000108	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.000107	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—atopic dermatitis	1.26e-05	0.000107	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—atopic dermatitis	1.24e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR5—atopic dermatitis	1.24e-05	0.000105	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MAPK8—atopic dermatitis	1.22e-05	0.000104	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—atopic dermatitis	1.21e-05	0.000103	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—atopic dermatitis	1.21e-05	0.000103	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—atopic dermatitis	1.2e-05	0.000102	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MAPK8—atopic dermatitis	1.18e-05	0.0001	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—atopic dermatitis	1.17e-05	9.89e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL8—atopic dermatitis	1.12e-05	9.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—atopic dermatitis	1.11e-05	9.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—atopic dermatitis	1.11e-05	9.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—atopic dermatitis	1.11e-05	9.4e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—atopic dermatitis	1.1e-05	9.37e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—atopic dermatitis	1.08e-05	9.13e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—atopic dermatitis	1.07e-05	9.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKBIA—atopic dermatitis	1.05e-05	8.89e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MAPK8—atopic dermatitis	1.02e-05	8.62e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—atopic dermatitis	9.89e-06	8.39e-05	CbGpPWpGaD
Gefitinib—ABCB1—head—atopic dermatitis	9.87e-06	0.00975	CbGeAlD
Gefitinib—IRAK1—Signaling Pathways—MAPK8—atopic dermatitis	9.83e-06	8.34e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—atopic dermatitis	9.71e-06	8.24e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARA—atopic dermatitis	9.48e-06	8.04e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARA—atopic dermatitis	8.95e-06	7.6e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARA—atopic dermatitis	8.16e-06	6.93e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—atopic dermatitis	7.82e-06	6.64e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—atopic dermatitis	7.54e-06	6.4e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL8—atopic dermatitis	7.47e-06	6.34e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARA—atopic dermatitis	7.33e-06	6.22e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARA—atopic dermatitis	7.15e-06	6.07e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—atopic dermatitis	7.14e-06	6.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—atopic dermatitis	7.1e-06	6.03e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARA—atopic dermatitis	6.74e-06	5.72e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARA—atopic dermatitis	6.68e-06	5.67e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MAPK8—atopic dermatitis	6.57e-06	5.58e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—atopic dermatitis	6.49e-06	5.51e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—atopic dermatitis	6.28e-06	5.32e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—atopic dermatitis	5.99e-06	5.08e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.41e-06	3.74e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—atopic dermatitis	4.2e-06	3.56e-05	CbGpPWpGaD
